ANDA 208263, held by Nesher Pharms. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 208263 (Doxycycline Hyclate), held by Nesher Pharms, was first approved by FDA on Nov 22, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 22, 2021 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 50MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters